Skip to main content

FDA Sets National Standards on Breast Density Notification

Posted March 10, 2023

Potential benefits/harms of delayed medical care during COVID

Posted December 15, 2020

Are women with a personal history of breast cancer receiving guideline-appropriate breast imaging exams?

Posted October 22, 2019

Are women with a personal history of breast cancer receiving guideline-appropriate breast imaging exams? Background National patterns of breast imaging in women with a personal history of breast cancer (PHBC) are unknown making evaluation of annual surveillance recommendations a challenge. Objective To describe variation in use of mammography and breast… Read More »

Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer

Posted October 23, 2018

There is little evidence on population-based harms and benefits of screening breast magnetic resonance imaging (MRI) in women with and without a personal history of breast cancer (PHBC). The objective of this study is to evaluate biopsy rates and yield in the 90 days following screening (mammography vs. magnetic resonance… Read More »

Cumulative Risk Distribution for Invasive Second Breast Cancers After Negative Surveillance Mammography

Posted October 23, 2018

The aim of the current study was to characterize the risk of interval invasive second breast cancers within 5 years of primary breast cancer treatment. We examined 65,084 surveillance mammograms from 18,366 women with a primary breast cancer diagnosis of unilateral ductal carcinoma in situ or stage I to III… Read More »

Preoperative Breast Magnetic Resonance Imaging Use by Breast Density and Family History of Breast Cancer

Posted October 23, 2018

Use of preoperative breast magnetic resonance imaging (MRI) among women with a new breast cancer has increased over the past decade. MRI use is more frequent in younger women and those with lobular carcinoma, but associations with breast density and family history of breast cancer are unknown. Data for 3,075… Read More »

Increased Risk of Developing Breast Cancer after a False-Positive Screening Mammogram

Posted December 4, 2015

Using 1994 to 2009 Breast Cancer Surveillance Consortium data, Henderson et al. included women ages 40 to 74 years with a screening mammogram that resulted in a false-positive with recommendation for additional imaging, false-positive with recommendation for biopsy, or true-negative with no cancer within one year following the examination. During… Read More »

Breast Cancer Characteristics Associated with Digital versus Film-Screen Mammography for Screen-Detected and Interval Cancers

Posted November 11, 2015

In an effort to determine if pathologic findings of screen-detected and interval cancers differ for digital versus film mammography, the Breast Cancer Surveillance Consortium (BCSC) data from 2003-2011 was used. Over 3 million screening mammograms (40.3% digital, 59.7% film) for women aged 40-89 years were reviewed. Among 15,729 breast cancers,… Read More »

Performance of Digital Screening Mammography in a Population-Based Cohort of Black and White Women

Posted November 11, 2015

Using CMR data from 2005-2010, we sought to examine whether digital screening mammography performance differs between black and white women. We examined 256,470 digital screening mammograms performed among 31,654 black and 133,152 white women aged 40 years or older. Among the study participants breast cancer was diagnosed in 276 black and… Read More »

Breast Tumor Prognostic Characteristics and Biennial vs. Annual Mammography, Age, and Menopausal Status

Posted November 10, 2015

A new study published in October of 2015 compared the proportion of breast cancers with less vs. more favorable prognostic characteristics in women screening annually vs. biennially by age, menopausal status, and postmenopausal hormone therapy (HT) use. Using a log-binomial regression to model the proportion of breast cancers with less… Read More »